Clinical trial update: International Breast Cancer Study Group

Karen N Price¹ and Aron Goldhirsch²^,3 for the International Breast Cancer Study Group

¹International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, Massachusetts, USA

²Oncology Institute of Southern Switzerland, Bellinzona, Mendrisio, Lugano, Switzerland

³European Institute of Oncology, Milan, Italy

author email corresponding author email

Breast Cancer Research 2005, 7:252-254doi:10.1186/bcr1334


Published:	4 October 2005

Abstract

The International Breast Cancer Study Group (IBCSG) has been conducting large, phase III clinical trials since 1978. Prior to 1986, these activities were carried out under the name of Ludwig Breast Cancer Study Group. Seven trials of adjuvant therapies are currently open for patient accrual, five of which are described in this report. The IBCSG has been a leader in the field of tailored treatment approaches for specific subpopulations of patients with breast cancer, believing that what is best for the majority may not be best for a defined minority.